(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MARUMAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MARUMAB

ST13

US500000088525639

Class

1, 5, 42

Filing

88525639

Registration

6224972

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

12/23/2025

Trademark type

Word

Nice classes

1, 5, 42

Filing date

07/20/2019

Registration date

12/22/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/22/2020

Last transaction

12/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

Daejeon, KR

Examiner

CHHINA,KARANENDRA S

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ORUM THERAPEUTICS INC.

Representatives

Steven J. Hultquist HULTQUIST, PLLC

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

monoclonal antibodies for scientific purposesantibodies for scientific purposes

Class 5

antibodies for medical purposesantibodies for medical usemonoclonal antibodies for medical purposes

Class 42

medical studies in the field of antibodies for scientific purposes; medical research in the field of antibodies

Publications

History of USPTO decisions and trademark events.

27 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/22/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/06/2020

PUBO

PUBLISHED FOR OPPOSITION

10/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/16/2020

ADBS

1(B) BASIS DELETED; NEW BASIS REQUESTED

09/02/2020

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

08/25/2020

APET

ASSIGNED TO PETITION STAFF

08/20/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/22/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/20/2020

EX1G

SOU EXTENSION 1 GRANTED

07/20/2020

EXT1

SOU EXTENSION 1 FILED

07/20/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/20/2020

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

07/20/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/21/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/26/2019

PUBO

PUBLISHED FOR OPPOSITION

11/26/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/06/2019

ALIE

ASSIGNED TO LIE

10/17/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/09/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

10/09/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/09/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

10/09/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/09/2019

DOCK

ASSIGNED TO EXAMINER

10/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2019

NWAP

NEW APPLICATION ENTERED

07/24/2019

Continuous trademark protection

Get notified about every new filing that threatens MARUMAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.